SLNSW-Cediranib or placebo in combination with cisplati...-TN_cdi_proquest_journals_1702710714

Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial

Full title: Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial

Author/creator: Valle, Juan W, Prof, Wasan, Harpreet, MD, Lopes, Andre, MSc, Backen, Alison C, PhD, Palmer, Daniel H, Prof, Morris, Karen, PhD, Duggan, Marian, MSc, Cunningham, David, Prof, Anthoney, D Alan, MD, Corrie, Pippa, MD, Madhusudan, Srinivasan, MD, Maraveyas, Anthony, Prof, Ross, Paul J, MD, Waters, Justin S, PhD, Steward, Will P, Prof, Rees, Charlotte, MD, Beare, Sandy, PhD, Dive, Caroline, Prof, Bridgewater, John A, MD.

Call Numbers:

Record Identifier: TN_cdi_proquest_journals_1702710714

Language: English

Formats: Articles

Publishers: England: Elsevier Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1702710714

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial

    Record identifier

    TN_cdi_proquest_journals_1702710714

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1702710714

    Share

    Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1702710714

    Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial

    Full title

    Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial

    Author / Creator

    Valle, Juan W, Prof ; Wasan, Harpreet, MD ; Lopes, Andre, MSc ; Backen, Alison C, PhD ; Palmer, Daniel H, Prof ; Morris, Karen, PhD ; Duggan, Marian, MSc ; Cunningham, David, Prof ; Anthoney, D Alan, MD ; Corrie, Pippa, MD ; Madhusudan, Srinivasan, MD ; Maraveyas, Anthony, Prof ; Ross, Paul J, MD ; Waters, Justin S, PhD ; Steward, Will P, Prof ; Rees, Charlotte, MD ; Beare, Sandy, PhD ; Dive, Caroline, Prof ; Bridgewater, John A, MD

    Publisher

    England: Elsevier Ltd

    Journal title

    The lancet oncology, 2015, Vol.16 (8), p.967-978

    Record Identifier

    TN_cdi_proquest_journals_1702710714

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Angiogenesis Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biliary Tract Neoplasms - drug therapy Biliary Tract Neoplasms - metabolism Biliary Tract Neoplasms - mortality Biliary Tract Neoplasms - pathology Biomarkers Cancer Cancer patients Cancer therapies Chemotherapy Cisplatin Cisplatin - administration & dosage Clinical trials Deoxycytidine - administration & dosage Deoxycytidine - analogs & derivatives Disease Disease Progression Disease-Free Survival Female Gallbladder Heart attacks Hematology, Oncology and Palliative Medicine Hospitals Humans Infections Intention to Treat Analysis Kaplan-Meier Estimate Male Medical colleges Medical prognosis Metastasis Mortality Ovarian cancer Product development Proportional Hazards Models Protein Kinase Inhibitors - administration & dosage Quinazolines - administration & dosage Receptors, Vascular Endothelial Growth Factor - antagonists & inhibitors Receptors, Vascular Endothelial Growth Factor - metabolism Rodents Studies Time Factors Treatment Outcome United Kingdom Vascular endothelial growth factor

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_proquest_journals_1702710714

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1702710714

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections